Tolerability of clobazam as add-on therapy in patients aged 50 years and older with drug-resistant epilepsy.

Elanagan NagarajanTimothy M LynchBridget FrawleyMarjorie E Bunch

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2023)

Clobazam can be a safe and tolerable, add-on treatment older adults with drug-resistant epilepsy. Those who responded tolerated the medication well. Discontinuation due to side effects occurred soon after initiation of therapy.

Keyphrases

drug resistant
multidrug resistant
acinetobacter baumannii
community dwelling
middle aged
physical activity
healthcare
emergency department
randomized controlled trial
combination therapy
adverse drug
cystic fibrosis
double blind
pseudomonas aeruginosa